BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37816983)

  • 1. Genetic variants of MTHFR gene in relation to folic acid levels and bone mineral density in Polish patients with inflammatory bowel disease.
    Ratajczak-Pawłowska AE; Hryhorowicz S; Szymczak-Tomczak A; Wysocka E; Michalak M; Kaczmarek-Ryś M; Lis-Tanaś E; Bielawska L; Pławski A; Słomski R; Dobrowolska A; Krela-Kaźmierczak I
    J Appl Genet; 2024 Feb; 65(1):73-81. PubMed ID: 37816983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D receptor (VDR) TaqI polymorphism, vitamin D and bone mineral density in patients with inflammatory bowel diseases.
    Szymczak-Tomczak A; Krela-Kaźmierczak I; Kaczmarek-Ryś M; Hryhorowicz S; Stawczyk-Eder K; Szalata M; Skrzypczak-Zielińska M; Łykowska-Szuber L; Eder P; Michalak M; Dobrowolska A; Słomski R
    Adv Clin Exp Med; 2019 Jul; 28(7):955-960. PubMed ID: 30929318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The c.29T>C polymorphism of the transforming growth factor beta-1 (TGFB1) gene, bone mineral density and the occurrence of low-energy fractures in patients with inflammatory bowel disease.
    Krela-Kaźmierczak I; Michalak M; Wawrzyniak A; Szymczak A; Eder P; Łykowska-Szuber L; Kaczmarek-Ryś M; Drwęska-Matelska N; Skrzypczak-Zielińska M; Linke K; Słomski R
    Mol Biol Rep; 2017 Dec; 44(6):455-461. PubMed ID: 28993955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Folate Intake on Bone Mineral Density in Patients with Inflammatory Bowel Disease.
    Ratajczak-Pawłowska AE; Szymczak-Tomczak A; Michalak M; Rychter AM; Zawada A; Skoracka K; Dobrowolska A; Krela-Kaźmierczak I
    Nutrients; 2023 Dec; 16(1):. PubMed ID: 38201836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physical activity, quality of diet and bone mineral density in patients with inflammatory bowel disease.
    Ratajczak-Pawłowska AE; Michalak M; Szymczak-Tomczak A; Rychter AM; Zawada A; Skoracka K; Dobrowolska A; Krela-Kaźmierczak I
    J Hum Nutr Diet; 2023 Oct; 36(5):1692-1700. PubMed ID: 37403249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk Factors of Low Bone Mineral Density in Newly Diagnosed Pediatric Inflammatory Bowel Disease.
    Ahn MB; Yoo IH
    Nutrients; 2023 Dec; 15(24):. PubMed ID: 38140307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone density and bone metabolism in patients with inflammatory bowel disease.
    Shirazi KM; Somi MH; Rezaeifar P; Fattahi I; Khoshbaten M; Ahmadzadeh M
    Saudi J Gastroenterol; 2012; 18(4):241-7. PubMed ID: 22824766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D, Vitamin D Receptor (VDR) Gene Polymorphisms (ApaI and FokI), and Bone Mineral Density in Patients With Inflammatory Bowel Disease.
    Szymczak-Tomczak A; Kaczmarek-Ryś M; Hryhorowicz S; Michalak M; Eder P; Skrzypczak-Zielińska M; Łykowska-Szuber L; Tomczak M; Słomski R; Dobrowolska A; Krela-Kaźmierczak I
    J Clin Densitom; 2021; 24(2):233-242. PubMed ID: 33172802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Updated bone mineral density status in Saudi patients with inflammatory bowel disease.
    Ewid M; Al Mutiri N; Al Omar K; Shamsan AN; Rathore AA; Saquib N; Salaas A; Al Sarraj O; Nasri Y; Attal A; Tawfiq A; Sherif H
    World J Gastroenterol; 2020 Sep; 26(35):5343-5353. PubMed ID: 32994692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of osteoporosis and osteopenia in a population of patients with inflammatory bowel diseases from the Wielkopolska Region.
    Krela-Kaźmierczak I; Michalak M; Szymczak-Tomczak A; Łykowska-Szuber L; Stawczyk-Eder K; Waszak K; Kucharski MA; Dobrowolska A; Eder P
    Pol Arch Intern Med; 2018 Aug; 128(7-8):447-454. PubMed ID: 30057387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone mineral density and the 570A>T polymorphism of the bone morphogenetic protein 2 (BMP2) gene in patients with inflammatory bowel disease: a cross-sectional study.
    Krela-Kazmierczak I; Wawrzyniak A; Szymczak A; Eder P; Lykowska-Szuber L; Michalak M; Drweska-Matelska N; Kaczmarek-Rys M; Skrzypczak-Zielinska M; Szalata M; Slomski R
    J Physiol Pharmacol; 2017 Oct; 68(5):757-764. PubMed ID: 29375051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The genetically predicted causal relationship of inflammatory bowel disease with bone mineral density and osteoporosis: evidence from two-sample Mendelian randomization.
    Xu D; Chen Y; Gao X; Xie W; Wang Y; Shen J; Yang G; Xie B
    Front Immunol; 2023; 14():1148107. PubMed ID: 37275908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Germline variation in the MTHFR and MTRR genes determines the nadir of bone density in pediatric acute lymphoblastic leukemia: a prospective study.
    te Winkel ML; de Muinck Keizer-Schrama SM; de Jonge R; van Beek RD; van der Sluis IM; Hop WC; Pieters R; van den Heuvel-Eibrink MM
    Bone; 2011 Mar; 48(3):571-7. PubMed ID: 20955826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk Factors for Low Bone Density in Inflammatory Bowel Disease: Use of Glucocorticoids, Low Body Mass Index, and Smoking.
    Even Dar R; Mazor Y; Karban A; Ish-Shalom S; Segal E
    Dig Dis; 2019; 37(4):284-290. PubMed ID: 30799399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bone mineral density in inflammatory bowel diseases in children].
    Szumera M; Landowski P; Kamińska B; Góra-Gebka M; Popadiuk S; Renke J
    Med Wieku Rozwoj; 2006; 10(2):445-51. PubMed ID: 16825715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone mineral density in patients with inflammatory bowel disease: a population-based prospective two-year follow-up study.
    Jahnsen J; Falch JA; Mowinckel P; Aadland E
    Scand J Gastroenterol; 2004 Feb; 39(2):145-53. PubMed ID: 15000276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylenetetrahydrofolate reductase C677T variant in Moroccan patients with inflammatory bowel disease.
    Senhaji N; Serbati N; Diakité B; Arazzakou S; Hamzi K; Badre W; Nadifi S
    Gene; 2013 May; 521(1):45-9. PubMed ID: 23542077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone mineral density in Iranian patients with inflammatory bowel disease.
    Zali M; Bahari A; Firouzi F; Daryani NE; Aghazadeh R; Emam MM; Rezaie A; Shalmani HM; Naderi N; Maleki B; Sayyah A; Bashashati M; Jazayeri H; Zand S
    Int J Colorectal Dis; 2006 Dec; 21(8):758-66. PubMed ID: 16463035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced bone mass and preserved marrow adipose tissue in patients with inflammatory bowel diseases in long-term remission.
    Bastos CM; Araújo IM; Nogueira-Barbosa MH; Salmon CEG; de Paula FJA; Troncon LEA
    Osteoporos Int; 2017 Jul; 28(7):2167-2176. PubMed ID: 28405731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between the methylenetetrahydrofolate reductase c.677C>T polymorphism and bone mineral density: an updated meta-analysis.
    Li HZ; Wang W; Liu YL; He XF
    Mol Genet Genomics; 2016 Feb; 291(1):169-80. PubMed ID: 26231982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.